Your browser doesn't support javascript.
loading
Driving Pressure-limited Strategy for Patients with Acute Respiratory Distress Syndrome. A Pilot Randomized Clinical Trial.
Pereira Romano, Marcelo Luz; Maia, Israel Silva; Laranjeira, Ligia Nasi; Damiani, Lucas Petri; Paisani, Denise de Moraes; Borges, Marcos de Carvalho; Dantas, Bruno Guimarães; Caser, Eliana Bernadete; Victorino, Josué Almeida; Filho, Wilson de Oliveira; Amato, Marcelo Britto Passos; Cavalcanti, Alexandre Biasi.
Afiliação
  • Pereira Romano ML; HCor Research Institute, São Paulo, Brazil.
  • Maia IS; Postgraduate Program of Anesthesiology, Surgical Sciences and Perioperative Medicine-Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Laranjeira LN; Hospital Nereu Ramos, Florianópolis, Brazil.
  • Damiani LP; HCor Research Institute, São Paulo, Brazil.
  • Paisani DM; HCor Research Institute, São Paulo, Brazil.
  • Borges MC; HCor Research Institute, São Paulo, Brazil.
  • Dantas BG; Unidade de Emergência do Hospital das Clínicas da FMRP-USP, Ribeirão Preto, Brazil.
  • Caser EB; Unidade de Emergência do Hospital das Clínicas da FMRP-USP, Ribeirão Preto, Brazil.
  • Victorino JA; Hospital Unimed Vitória, Vitória, Brazil.
  • Filho WO; Hospital Cristo Redentor, Porto Alegre, Brazil.
  • Amato MBP; Hospital e Pronto-Socorro 28 de Agosto, Manaus, Brazil; and.
  • Cavalcanti AB; Cardio-Pulmonary Department, Pulmonary Division, Heart Institute, University of São Paulo, São Paulo, Brazil.
Ann Am Thorac Soc ; 17(5): 596-604, 2020 05.
Article em En | MEDLINE | ID: mdl-32069068
ABSTRACT
Rationale Evidence from observational studies suggests that driving pressure is strongly associated with pulmonary injury and mortality, regardless of positive end-expiratory pressure (PEEP) levels, tidal volume, or plateau pressure. Therefore, it is possible that targeting driving pressure may improve the safety of ventilation strategies for patients with acute respiratory distress syndrome (ARDS). However, the clinical effects of a driving pressure-limited strategy for ARDS has not been assessed in randomized controlled trials.

Objectives:

To evaluate the feasibility of testing a driving pressure-limited strategy in comparison with a conventional lung-protective ventilation strategy in patients with ARDS and a baseline driving pressure of ≥13 cm H2O.

Methods:

This was a randomized, controlled, nonblinded trial that included 31 patients with ARDS who were on invasive mechanical ventilation and had a driving pressure of ≥13 cm H2O. Patients allocated to the driving pressure-limited strategy were ventilated with volume-controlled or pressure-support ventilation modes, with tidal volume titrated to 4-8 ml/kg of predicted body weight (PBW), aiming at a driving pressure of 10 cm H2O, or the lowest possible. Patients in the control group were ventilated according to the ARDSNet (Acute Respiratory Distress Syndrome Network) protocol, using a tidal volume of 6 ml/kg PBW, which was allowed to be set down to 4 ml/kg PBW if the plateau pressure was >30 cm H2O. The primary endpoint was the driving pressure on Days 1-3.

Results:

Sixteen patients were randomized to the driving pressure-limited group and 15 were randomized to the conventional strategy group. All patients were considered in analyses. Most of the patients had mild ARDS with a mean arterial oxygen tension/fraction of inspired oxygen ratio of 215 (standard deviation [SD] = 95). The baseline driving pressure was 15.0 cm H2O (SD = 2.6) in both groups. In comparison with the conventional strategy, driving pressure from the first hour to the third day was 4.6 cm H2O lower in the driving pressure-limited group (95% confidence interval [CI], 6.5 to 2.8; P < 0.001). From the first hour up to the third day, tidal volume in the driving pressure-limited strategy group was kept lower than in the control group (mean difference [ml/kg of PBW], 1.3; 95% CI, 1.7 to 0.9; P < 0.001). We did not find statistically significant differences in the incidence of severe acidosis (pH < 7.10) within 7 days (absolute difference -12.1; 95% CI, -41.5 to -17.3) or any clinical secondary endpoint.

Conclusions:

In patients with ARDS, a trial assessing the effects of a driving pressure-limited strategy using very low tidal volumes versus a conventional ventilation strategy on clinical outcomes is feasible.Clinical trial registered with ClinicalTrials.gov (NCT02365038).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Desconforto Respiratório / Respiração com Pressão Positiva Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Am Thorac Soc Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Desconforto Respiratório / Respiração com Pressão Positiva Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Am Thorac Soc Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil